sb 203580 has been researched along with glucosamine in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (glucosamine) | Trials (glucosamine) | Recent Studies (post-2010) (glucosamine) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 10,273 | 280 | 1,467 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, MS; Hong, H; Jang, BC; Nam, KY; Park, GY; Park, YK; Ryu, NH; Song, DK; Suh, SI | 1 |
1 other study(ies) available for sb 203580 and glucosamine
Article | Year |
---|---|
Differential down-regulation of COX-2 and MMP-13 in human skin fibroblasts by glucosamine-hydrochloride.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Carcinogens; Cell Line; Cyclooxygenase 2; Down-Regulation; Enzyme Inhibitors; Fibroblasts; Glucosamine; Humans; Imidazoles; Interleukin-1beta; Keratinocytes; Matrix Metalloproteinase 13; Matrix Metalloproteinase Inhibitors; Protein Kinases; Pyridines; Skin; Tetradecanoylphorbol Acetate | 2009 |